Publication | Closed Access

Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial

Weekly Versus SitagliptinDiabetes ManagementRandomised TrialDiabetesPharmacologyClinical TrialsType 2PharmacotherapyDiabetes MellitusInsulin DeliveryMedicine